Secondary |
Psychotic Disorder |
17.8% |
Depression |
13.3% |
Interstitial Lung Disease |
13.3% |
Polymyositis |
13.3% |
Insomnia |
8.9% |
Panic Disorder |
8.9% |
Suicide Attempt |
6.7% |
Androgenetic Alopecia |
4.4% |
Gastric Disorder |
4.4% |
Gastritis Prophylaxis |
4.4% |
Hyperlipidaemia |
4.4% |
|
Hepatic Function Abnormal |
18.2% |
Interstitial Lung Disease |
18.2% |
Fall |
9.1% |
Pyrexia |
9.1% |
Rash |
9.1% |
Respiratory Acidosis |
9.1% |
Septic Shock |
9.1% |
Somnolence |
9.1% |
Viral Upper Respiratory Tract Infection |
9.1% |
|
Concomitant |
Product Used For Unknown Indication |
18.5% |
Drug Use For Unknown Indication |
10.7% |
Prophylaxis |
10.7% |
Insomnia |
8.4% |
Back Pain |
7.7% |
Depression |
6.2% |
Hypertension |
5.5% |
Rheumatoid Arthritis |
4.9% |
Breast Cancer |
3.4% |
Anxiety |
2.8% |
Non-small Cell Lung Cancer |
2.7% |
Constipation Prophylaxis |
2.5% |
Sleep Disorder Therapy |
2.5% |
Mineral Supplementation |
2.4% |
Crohn's Disease |
2.1% |
Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
Liver Transplant |
1.9% |
Chronic Hepatitis C |
1.8% |
Agitation |
1.6% |
Aspergillosis |
1.6% |
|
Vomiting |
12.1% |
Intestinal Obstruction |
8.8% |
Encephalopathy |
7.7% |
Progressive Multifocal Leukoencephalopathy |
6.6% |
Somnolence |
6.6% |
Syncope |
5.5% |
Nausea |
4.4% |
Nephrolithiasis |
4.4% |
Pulmonary Embolism |
4.4% |
Renal Failure |
4.4% |
Stress |
4.4% |
Weight Decreased |
4.4% |
Blood Lactate Dehydrogenase Increased |
3.3% |
Cerebral Haemorrhage |
3.3% |
Diarrhoea |
3.3% |
Hypertension |
3.3% |
Malaise |
3.3% |
Neutropenic Sepsis |
3.3% |
Oedema |
3.3% |
Pancreatitis Acute |
3.3% |
|
Interacting |
Atrial Fibrillation |
28.6% |
Hypertension |
14.3% |
Major Depression |
14.3% |
Parkinson's Disease |
14.3% |
Prophylaxis Against Gastrointestinal Ulcer |
14.3% |
Renal Failure Chronic |
14.3% |
|
Leukoencephalopathy |
50.0% |
Pericardial Haemorrhage |
50.0% |
|